After shedding its cancer business just over a decade ago, GSK’s new CEO is building back with a $10.6 billion deal

8 hours ago 2
After shedding its oncology concern conscionable implicit a decennary ago, GSK is gathering it backmost with a $10.6 cardinal deal.
Read Entire Article